210 related articles for article (PubMed ID: 15390186)
1. Benzo[a]pyrene diol epoxide-induced 9p21 aberrations associated with genetic predisposition to bladder cancer.
Hazra A; Grossman HB; Zhu Y; Luo S; Spitz MR; Wu X
Genes Chromosomes Cancer; 2004 Dec; 41(4):330-8. PubMed ID: 15390186
[TBL] [Abstract][Full Text] [Related]
2. Benzo(a)pyrene diol epoxide-induced chromosome 9p21 aberrations are associated with increased risk of bladder cancer.
Gu J; Horikawa Y; Chen M; Dinney CP; Wu X
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2445-50. PubMed ID: 18768515
[TBL] [Abstract][Full Text] [Related]
3. Benzo[a]pyrene diol epoxide-induced 3p21.3 aberrations and genetic predisposition to lung cancer.
Wu X; Zhao Y; Honn SE; Tomlinson GE; Minna JD; Hong WK; Spitz MR
Cancer Res; 1998 Apr; 58(8):1605-8. PubMed ID: 9563468
[TBL] [Abstract][Full Text] [Related]
4. Chromosome instability in lymphocytes: a potential indicator of predisposition to oral premalignant lesions.
Wu X; Lippman SM; Lee JJ; Zhu Y; Wei QV; Thomas M; Hong WK; Spitz MR
Cancer Res; 2002 May; 62(10):2813-8. PubMed ID: 12019158
[TBL] [Abstract][Full Text] [Related]
5. BPDE-induced lymphocytic 3p21.3 aberrations may predict head and neck carcinoma risk.
Zhu Y; Spitz MR; Zheng YL; Hong WK; Wu X
Cancer; 2002 Aug; 95(3):563-8. PubMed ID: 12209748
[TBL] [Abstract][Full Text] [Related]
6. Benzo(a)pyrene diol epoxide-induced chromosomal aberrations and risk of lung cancer.
Wei Q; Gu J; Cheng L; Bondy ML; Jiang H; Hong WK; Spitz MR
Cancer Res; 1996 Sep; 56(17):3975-9. PubMed ID: 8752166
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity to DNA damage induced by benzo(a)pyrene diol epoxide and risk of lung cancer: a case-control analysis.
Li D; Firozi PF; Wang LE; Bosken CH; Spitz MR; Hong WK; Wei Q
Cancer Res; 2001 Feb; 61(4):1445-50. PubMed ID: 11245449
[TBL] [Abstract][Full Text] [Related]
8. Specific chromosome aberrations in peripheral blood lymphocytes are associated with risk of bladder cancer.
Shao L; Lerner SL; Bondaruk J; Czerniak BA; Zeng X; Grossman HB; Spitz MR; Wu X
Genes Chromosomes Cancer; 2004 Dec; 41(4):379-89. PubMed ID: 15390184
[TBL] [Abstract][Full Text] [Related]
9. A parallel study of in vitro sensitivity to benzo[a]pyrene diol epoxide and bleomycin in lung carcinoma cases and controls.
Wu X; Gu J; Amos CI; Jiang H; Hong WK; Spitz MR
Cancer; 1998 Sep; 83(6):1118-27. PubMed ID: 9740076
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity to benzo(a)pyrene diol-epoxide associated with risk of breast cancer in young women and modulation by glutathione S-transferase polymorphisms: a case-control study.
Xiong P; Bondy ML; Li D; Shen H; Wang LE; Singletary SE; Spitz MR; Wei Q
Cancer Res; 2001 Dec; 61(23):8465-9. PubMed ID: 11731429
[TBL] [Abstract][Full Text] [Related]
11. Mutagen sensitivity to benzo(a)pyrene diol epoxide and the risk of squamous cell carcinoma of the head and neck.
Wang LE; Sturgis EM; Eicher SA; Spitz MR; Hong WK; Wei Q
Clin Cancer Res; 1998 Jul; 4(7):1773-8. PubMed ID: 9676854
[TBL] [Abstract][Full Text] [Related]
12. Mutability of p53 hotspot codons to benzo(a)pyrene diol epoxide (BPDE) and the frequency of p53 mutations in nontumorous human lung.
Hussain SP; Amstad P; Raja K; Sawyer M; Hofseth L; Shields PG; Hewer A; Phillips DH; Ryberg D; Haugen A; Harris CC
Cancer Res; 2001 Sep; 61(17):6350-5. PubMed ID: 11522624
[TBL] [Abstract][Full Text] [Related]
13. In vitro induction of benzo(a)pyrene diol epoxide-DNA adducts in peripheral lymphocytes as a susceptibility marker for human lung cancer.
Li D; Wang M; Cheng L; Spitz MR; Hittelman WN; Wei Q
Cancer Res; 1996 Aug; 56(16):3638-41. PubMed ID: 8705998
[TBL] [Abstract][Full Text] [Related]
14. Chromosomal alterations and mutagen sensitivity in human mucosal cells of the oropharynx and lymphocytes caused by BPDE.
Reiter M; Baumeister P; Zieger S; Harréus U
Cancer Genomics Proteomics; 2009; 6(5):247-54. PubMed ID: 19996129
[TBL] [Abstract][Full Text] [Related]
15. Reduced DNA repair of benzo[a]pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients.
Shi Q; Wang LE; Bondy ML; Brewster A; Singletary SE; Wei Q
Carcinogenesis; 2004 Sep; 25(9):1695-700. PubMed ID: 15090466
[TBL] [Abstract][Full Text] [Related]
16. Reduced DNA repair capacity in lung cancer patients.
Wei Q; Cheng L; Hong WK; Spitz MR
Cancer Res; 1996 Sep; 56(18):4103-7. PubMed ID: 8797573
[TBL] [Abstract][Full Text] [Related]
17. Mutagen sensitivity as a susceptibility marker for human hepatocellular carcinoma.
Wu X; Gu J; Patt Y; Hassan M; Spitz MR; Beasley RP; Hwang LY
Cancer Epidemiol Biomarkers Prev; 1998 Jul; 7(7):567-70. PubMed ID: 9681523
[TBL] [Abstract][Full Text] [Related]
18. In vitro benzo[a]pyrene diol epoxide-induced DNA damage and chromosomal aberrations in primary lymphocytes, smoking, and risk of squamous cell carcinoma of the head and neck.
Xiong P; Hu Z; Li C; Wang LE; El-Naggar AK; Sturgis EM; Wei Q
Int J Cancer; 2007 Dec; 121(12):2735-40. PubMed ID: 17724733
[TBL] [Abstract][Full Text] [Related]
19. Cigarette smoking and chromosome 9 alterations in bladder cancer.
Zhang ZF; Shu XM; Cordon-Cardo C; Orlow I; Lu ML; Millon TV; Cao PQ; Connolly-Jenks C; Dalbagni G; Lianes P; Lacombe L; Reuter VE; Scher H
Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):321-6. PubMed ID: 9149891
[TBL] [Abstract][Full Text] [Related]
20. Numerical aberrations of chromosome 17 and the 9p21 locus are independent predictors of tumor recurrence in non-invasive transitional cell carcinoma of the urinary bladder.
Krüger S; Mess F; Böhle A; Feller AC
Int J Oncol; 2003 Jul; 23(1):41-8. PubMed ID: 12792774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]